000			01663 a2200481 4500
005			20250517010914.0
264		0	_c20160307
008			201603s 0 0 eng d
022			_a1802-9973
024	7		_a10.33549/physiolres.932797 _2doi
040			_aNLM _beng _cNLM
100	1		_aŠilhavý, J
245	0	0	_aRosuvastatin ameliorates inflammation, renal fat accumulation, and kidney injury in transgenic spontaneously hypertensive rats expressing human C-reactive protein. _h[electronic resource]
260			_bPhysiological research _c2015
300			_a295-301 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Kidney Injury _xdrug therapy
650	0	4	_aAdiposity _xdrug effects
650	0	4	_aAnimals
650	0	4	_aC-Reactive Protein _xgenetics
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use
650	0	4	_aHypertension _xdrug therapy
650	0	4	_aInflammation _xdrug therapy
650	0	4	_aKidney _xdrug effects
650	0	4	_aMale
650	0	4	_aRats
650	0	4	_aRats, Inbred SHR
650	0	4	_aRats, Transgenic
650	0	4	_aRosuvastatin Calcium _xtherapeutic use
650	0	4	_aTreatment Outcome
700	1		_aZídek, V
700	1		_aLanda, V
700	1		_aŠimáková, M
700	1		_aMlejnek, P
700	1		_aOliyarnyk, O
700	1		_aMalínská, H
700	1		_aKazdová, L
700	1		_aMancini, M
700	1		_aPravenec, M
773	0		_tPhysiological research _gvol. 64 _gno. 3 _gp. 295-301
856	4	0	_uhttps://doi.org/10.33549/physiolres.932797 _zAvailable from publisher's website
999			_c24484246 _d24484246